Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity
Technology in Cancer Research & Treatment · 2024-01 · 23
DOI: 10.1177/15330338241260658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, online erschienen am 07.06.2024. Verfasst von Fengru Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, DNA (Cytosine-5-)-Methyltransferases, Tumor Microenvironment, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Discipline Construction Project of Pudong Health Bureau of Shanghai.
Abstract (Originalsprache)
Objective
DNA methylation is an essential epigenetic marker governed by DNA methyltransferases (DNMTs), which can influence cancer onset and progression. However, few studies have provided an integrated analysis of the relevance of DNMT family genes to cell stemness, the tumor microenvironment (TME), and immunotherapy biomarkers across diverse cancers.
Methods
This study investigated the impact of five DNMTs on transcriptional profiles, prognosis, and their association with Ki67 expression, epithelial–mesenchymal transition signatures, stemness scores, the TME, and immunological markers across 31 cancer types from recognized public databases.
Results
The results indicated that DNMT1/DNMT3B/DNMT3A expression increased, whereas TRDMT1/DNMT3L expression decreased in most cancer types. DNMT family genes were identified as prognostic risk factors for numerous cancers, as well as being prominently associated with immune, stromal, and ESTIMATE scores, as well as with immune-infiltrating cell levels. Expression of the well-known immune checkpoints, PDCD1 and CILA4, was noticeably related to DNMT1/DNMT3A/DNMT3B expression. Finally, we validated the role of DNMT1 in MCF-7 and HepG2-C3A cell lines through its knockdown, whereafter a decrease in cell proliferation and migration ability in vitro was observed.
Conclusion
Our study comprehensively expounded that DNMT family genes not only behave as promising prognostic factors but also have the potential to serve as therapeutic targets in cancer immunotherapy for various types of cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai, China.
- Tongji University Cancer Center, Shanghai Tenth People's Hospital of Tongji University, School of Medicine, Tongji University, Shanghai, China.
- Department of Hepatobiliary and Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Wencong Ma
Förderung
- Key Discipline Construction Project of Pudong Health Bureau of Shanghai
Zitieren
APA
Huang, F., Wu, X., Du, Q., Lin, J., Ma, W., & Liu, J. (2024). Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity. Technology in Cancer Research & Treatment, 23. https://doi.org/10.1177/15330338241260658
Vancouver
Huang F, Wu X, Du Q, Lin J, Ma W, Liu J. Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity. Technology in Cancer Research & Treatment. 2024;23. doi:10.1177/15330338241260658
BibTeX
@article{Huang2024,
author = {Huang, Fengru and Wu, Xinyi and Du, Qiong and Lin, Jianghua and Ma, Wencong and Liu, Jiyong},
title = {Systematic Characterization of DNA Methyltransferases Family in Tumor Progression and Antitumor Immunity},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
volume = {23},
doi = {10.1177/15330338241260658}
}
EUVIMED